Announcements
Projects
Orgs
Project
Articles 42
Votes 0
PMLiVE
Nanoparticle-delivered RNA could deliver potential therapy for neuroinflammation - PMLiVE
almost2y
Bristol Myers Squibb's Sotyktu accepted by SMC for plaque psoriasis - PMLiVE
almost2y
GSK and GCOA report reveals global inequities in adult immunisation uptake - PMLiVE
almost2y
Pfizer's RSV vaccine granted MHRA approval to protect infants and older adults - PMLiVE - PMLiVE
almost2y
Novavax's updated COVID-19 vaccine granted Emergency Use Listing by WHO - PMLiVE - PMLiVE
almost2y
WHO publishes new infodemic management tools for pandemic preparedness - PMLiVE
~2y
Pfizer and BioNTech’s COVID-19/flu combination vaccine shows promise in phase 1/2 study - PMLiVE
~2y
Differences in immune responses could optimise future COVID-19 vaccines - PMLiVE
~2y
New EU study highlights psychological challenges of living with skin diseases - PMLiVE
~2y
Research shows new scientific technique could halve polio detection times - PMLiVE
~2y
Resisting the resistance - PMLiVE - PMLiVE
~2y
Genetically altered vaccines developed to help eradicate polio - PMLiVE
>2y
UK Biobank study to review human ageing over time moves into second stage - PMLiVE - PMLiVE
>2y
MIT researchers develop AI model to detect future lung cancer risk - PMLiVE
almost3y
NICE recommends wider use of statins to cut risk of heart attack and stroke - PMLiVE
almost3y
First UK proton beam therapy trial launches for certain breast cancer patients - PMLiVE
almost3y
New research shows potential to treat kidney disease with common medicines - PMLiVE
almost3y
Genomics England receives government funding for cutting-edge genomics research - PMLiVE
almost3y
ICR and University of Cambridge reveal new prostate cancer prediction tool - PMLiVE
almost3y
New research shows potential to diagnose myocarditis with routine blood tests - PMLiVE
almost3y
Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer - PMLiVE
almost3y
New study links antioxidant flavonols to slower rate of memory decline - PMLiVE
almost3y
ICR and The Royal Marsden reveal plans to ‘disrupt’ cancer ecosystems - PMLiVE
almost3y
WHO launches R&D efforts to identify pathogens that could cause future pandemics - PMLiVE
almost3y
ICR calls for further discussions following NICE’s rejection of breast cancer drug - PMLiVE
almost3y